Beta-Blocker Clears Infancy Hemangiomas

Beta-Blocker Clears Infancy Hemangiomas

Filed under: drug treatment programs in maryland

After 24 weeks of continuous therapy, clearance rates were 60.4% with propranolol compared with 3.6% in the placebo group, reported Christine Léauté-Labrèze, MD, and colleagues at the American Academy of Dermatology meeting. Three other propranolol …
Read more on MedPage Today

Researchers discover how to shutdown cancer's powerful master protein

Filed under: drug treatment programs in maryland

In fact, the findings in this study were inspired from preclinical testing of two Bcl6-targeting agents that Dr. Melnick and his Weill Cornell colleagues have developed to treat DLBCLs. These experimental drugs are RI-BPI, a peptide mimic, and the …
Read more on EurekAlert (press release)

KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from …

Filed under: drug treatment programs in maryland

“In my practice, patients often request a non-surgical way to treat their submental fat, or undesirable double chin,” said investigator Susan Weinkle, MD, FAAD, a board certified dermatologist and affiliate clinical professor at the University of South …
Read more on Business Wire (press release)

Roche's trastuzumab emtansine receives FDA approval

Filed under: drug treatment programs in maryland

“Trastuzumab emtansine is an antibody-drug conjugate representing a completely new way to treat HER2-positive metastatic breast cancer, and it helped people in the EMILIA study live nearly six months longer,” said Hal Barron, M.D., Roche's chief …
Read more on Malaya